What does DR M-F SPADA do?

DR M-F SPADA is a specialist medical practice in Wezembeek-Oppem. Private Limited, started on 28 April 2006.

What is the address of DR M-F SPADA?

The registered office of DR M-F SPADA is located at Hoefijzerstraat 10, 1970 Wezembeek-Oppem.

Is DR M-F SPADA still active?

Yes. According to the CBE (17 September 2026) DR M-F SPADA is active, legal situation “Normale toestand”, started on 28 April 2006.

Is DR M-F SPADA registered on Peppol?

No, DR M-F SPADA is currently not registered on the Peppol network.

What is the enterprise number of DR M-F SPADA?

The enterprise number of DR M-F SPADA is BE0881028630.

When was DR M-F SPADA founded?

DR M-F SPADA was founded on 28 April 2006.

Who are the directors of DR M-F SPADA?

According to the 2025 annual accounts, the directors of DR M-F SPADA are: Maria Francesca SPADA.

Is DR M-F SPADA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 April 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR M-F SPADA make in 2025?

DR M-F SPADA posted a profit after taxes of € 102,036 in financial year 2025.

What is the revenue of DR M-F SPADA?

As a small company, DR M-F SPADA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 166,868.

DR M-F SPADA (Private Limited) - Wezembeek-Oppem

Dossier DR M-F SPADA, printed on 17 September 2026 from databakkes.be/en/0881028630/dr-m-f-spada. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DR M-F SPADA from Wezembeek-Oppem, company number BE0881028630, closed financial year 2025 with a result of € 102,036 after tax. For that financial year DR M-F SPADA recorded a gross margin of € 166,868 and equity of € 550,389. Compared with financial year 2024, the result moved from € 98,767 to € 102,036. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.

What it is worth Growing

€ 550,389

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 102,036

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 107,967

▲ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 37,670 paid out

37 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 929

▼ 34% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 59,134

▼ 30% vs 2024

€ 18,822 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 2,114

▲ 38% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 84,172

▲ 76% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 129,637 Gross margin 2022: € 129,637 First fiscal year in the series	€ 123,720 Gross margin 2023: € 123,720 ▼ 5% vs 2022 (€ 129,637) Unfavourable step	€ 147,159 Gross margin 2024: € 147,159 ▲ 19% vs 2023 (€ 123,720) Favourable step	€ 166,868 Gross margin 2025: € 166,868 ▲ 13% vs 2024 (€ 147,159) Favourable step	▲ 13%
Profit after taxes	€ 84,725 Profit after taxes 2022: € 84,725 First fiscal year in the series	€ 81,725 Profit after taxes 2023: € 81,725 ▼ 4% vs 2022 (€ 84,725) Unfavourable step	€ 98,767 Profit after taxes 2024: € 98,767 ▲ 21% vs 2023 (€ 81,725) Favourable step	€ 102,036 Profit after taxes 2025: € 102,036 ▲ 3% vs 2024 (€ 98,767) Favourable step	▲ 3%
Equity	€ 410,061 Equity 2022: € 410,061 First fiscal year in the series	€ 459,786 Equity 2023: € 459,786 ▲ 12% vs 2022 (€ 410,061) Favourable step	€ 486,023 Equity 2024: € 486,023 ▲ 6% vs 2023 (€ 459,786) Favourable step	€ 550,389 Equity 2025: € 550,389 ▲ 13% vs 2024 (€ 486,023) Favourable step	▲ 13%
Total debts	€ 255,027 Total debts 2022: € 255,027 First fiscal year in the series	€ 217,529 Total debts 2023: € 217,529 ▼ 15% vs 2022 (€ 255,027) Favourable step	€ 206,994 Total debts 2024: € 206,994 ▼ 5% vs 2023 (€ 217,529) Favourable step	€ 183,489 Total debts 2025: € 183,489 ▼ 11% vs 2024 (€ 206,994) Favourable step	▼ 11%
Cash	€ 112,021 Cash 2022: € 112,021 First fiscal year in the series	€ 99,526 Cash 2023: € 99,526 ▼ 11% vs 2022 (€ 112,021) Unfavourable step	€ 95,033 Cash 2024: € 95,033 ▼ 5% vs 2023 (€ 99,526) Unfavourable step	€ 107,967 Cash 2025: € 107,967 ▲ 14% vs 2024 (€ 95,033) Favourable step	▲ 14%
Land & buildings	€ 151,071 Land & buildings 2022: € 151,071 First fiscal year in the series	€ 152,279 Land & buildings 2023: € 152,279 ▲ 1% vs 2022 (€ 151,071) Unchanged	€ 145,806 Land & buildings 2024: € 145,806 ▼ 4% vs 2023 (€ 152,279) Unchanged	€ 145,664 Land & buildings 2025: € 145,664 Unchanged (€ 145,806) Unchanged
Retained profit	€ 391,461 Retained profit 2022: € 391,461 First fiscal year in the series	€ 441,186 Retained profit 2023: € 441,186 ▲ 13% vs 2022 (€ 391,461) Favourable step	€ 467,423 Retained profit 2024: € 467,423 ▲ 6% vs 2023 (€ 441,186) Favourable step	€ 531,789 Retained profit 2025: € 531,789 ▲ 14% vs 2024 (€ 467,423) Favourable step	▲ 14%
Dividend	€ 46,000 Dividend 2022: € 46,000 First fiscal year in the series	€ 32,000 Dividend 2023: € 32,000 ▼ 30% vs 2022 (€ 46,000) Unchanged	€ 72,530 Dividend 2024: € 72,530 ▲ 127% vs 2023 (€ 32,000) Unchanged	€ 37,670 Dividend 2025: € 37,670 ▼ 48% vs 2024 (€ 72,530) Unchanged	▼ 48%
Bank debt	€ 127,531 Bank debt 2022: € 127,531 First fiscal year in the series	€ 105,427 Bank debt 2023: € 105,427 ▼ 17% vs 2022 (€ 127,531) Favourable step	€ 85,070 Bank debt 2024: € 85,070 ▼ 19% vs 2023 (€ 105,427) Favourable step	€ 59,134 Bank debt 2025: € 59,134 ▼ 30% vs 2024 (€ 85,070) Favourable step	▼ 30%
Balance sheet total	€ 665,088 Balance sheet total 2022: € 665,088 First fiscal year in the series	€ 677,316 Balance sheet total 2023: € 677,316 ▲ 2% vs 2022 (€ 665,088) Unchanged	€ 693,017 Balance sheet total 2024: € 693,017 ▲ 2% vs 2023 (€ 677,316) Unchanged	€ 733,878 Balance sheet total 2025: € 733,878 ▲ 6% vs 2024 (€ 693,017) Unchanged	▲ 6%

Key figures of DR M-F SPADA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR M-F SPADA?

What happened at DR M-F SPADA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 30, 2026 New annual accounts for financial year 2025: profit of € 102,036 (▲ 3% vs 2024). filed late Source: NBB ↗
2006 Maria Francesca SPADA became a director. NBB
Apr 28, 2006 Start of the company according to the CBE. KBO

In short

From € 84,725 profit in 2022 to € 102,036 profit in 2025.

Paid € 168,270 in corporate taxes since 2022.

Best year ever: 2025, with € 102,036 profit.

Paid out € 188,200 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR M-F SPADA? We notify you, reason included.

Follow DR M-F SPADA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Maria Francesca SPADA

DR M-F SPADA

Behind DR M-F SPADA is Maria Francesca SPADA.

See the full network in the app

Directors

According to the 2025 annual accounts

Maria Francesca SPADA

Director

since 2006

Establishments

Establishment units

Physical locations of this company

Registered office

Hoefijzerstraat 10

1970 Wezembeek-Oppem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0881.028.630
VAT number: BE 0881.028.630
Registered office: Hoefijzerstraat 10, 1970 Wezembeek-Oppem
Names & denominations: DR M-F SPADA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 April 2006
Peppol: Not registered
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗